scholarly journals Traditional warfarin (Coumadin) therapy usage experience on nonvalvular atrial fibrillation before non-Vitamin K antagonists (new oral anticoagulants) era from a center in Turkey

2020 ◽  
Vol 6 (2) ◽  
pp. 66
Author(s):  
Emre Ozdemir ◽  
Ozgen Safak ◽  
SadikVolkan Emren ◽  
MehmetSerdar Bayata
Keyword(s):  
Atrial Fibrillation ◽  
Vitamin K ◽  
Vitamin K Antagonists ◽  
Oral Anticoagulants ◽  
New Oral Anticoagulants ◽  
Nonvalvular Atrial Fibrillation

scholarly journals New Oral Anticoagulants vs Vitamin K Antagonists: Benefits for Health-Related Quality of Life in Patients with Atrial Fibrillation

2014 ◽  
Vol 11 (7) ◽  
pp. 680-684 ◽  
Author(s):  
Josep M. Alegret ◽  
Xavier Viñolas ◽  
Miguel A. Arias ◽  
Antoni Martínez-Rubio ◽  
Pablo Rebollo ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Atrial Fibrillation ◽  
Vitamin K ◽  
Vitamin K Antagonists ◽  
Oral Anticoagulants ◽  
New Oral Anticoagulants ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related

scholarly journals Satisfaction With Medical Care in Patients With Atrial Fibrillation Treated With Vitamin K Antagonists Versus New Oral Anticoagulants

2015 ◽  
Vol 68 (6) ◽  
pp. 537-539 ◽  
Author(s):  
Manuel Anguita ◽  
Francisco Marín ◽  
Inmaculada Roldán ◽  
Angel Cequier ◽  
Vicente Bertomeu ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Medical Care ◽  
Vitamin K ◽  
Vitamin K Antagonists ◽  
Oral Anticoagulants ◽  
New Oral Anticoagulants

One decade of oral anticoagulation in stroke patients: Results from a large country-wide hospital-based registry

2017 ◽  
Vol 13 (3) ◽  
pp. 308-312 ◽  
Author(s):  
Christian Tanislav ◽  
Jens Allendörfer ◽  
Waltraud Pfeilschifter ◽  
Sven Fuest ◽  
Marco Stein ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Vitamin K ◽  
Vitamin K Antagonists ◽  
Oral Anticoagulants ◽  
New Oral Anticoagulants ◽  
Federal State ◽  
Stroke Patients ◽  
Large Country ◽  
Previous Medication ◽  
Ischemic Attack

Background New evidence regarding stroke prevention in atrial fibrillation has been published. Implementing knowledge into clinical practice remains challenging. Aims To investigate oral anticoagulants in stroke patients documented in a nationwide registry. Methods The database is an obligatory federal-state-wide hospital-based registry that covers more than 95% of all ischemic strokes, transient ischemic attacks and intracerebral hemorrhages in a community of more than six million inhabitants (Hesse/Germany). We analyzed oral anticoagulants prescribed on discharge in patients with stroke or transient ischemic attack during 2006–2015. Results From 2006 to 2015, we annually selected median 20,895 patients. From 2006 to 2015, the proportion of patients treated with oral anticoagulants increased (9.8% to 24%). The annual proportion of patients with atrial fibrillation remained constant (median: 23%). In atrial fibrillation patients treated with oral anticoagulants, the age increased (median 2008/2009: 76.9 years vs. 2014/2015 79.4 years). The percentage of treated individuals in atrial fibrillation increased dramatically (2006: 30.1% to 2015: 74.5%); in 2015, 30.8% of these patients received vitamin K antagonists and 70.2% new oral anticoagulants. Independent factors associated with new oral anticoagulants therapy were a previous medication with new oral anticoagulants and a treatment on stroke unit. Between new oral anticoagulants- and vitamin K antagonists-treated patients (2015), no differences in age were noted (both mean: 79.4 years). Conclusions The new oral anticoagulants availability enhanced a general trend treating more target patients with oral anticoagulants.

Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study

2020 ◽  
Vol 73 (1) ◽  
pp. 14-20
Author(s):  
Manuel Anguita Sánchez ◽  
Vicente Bertomeu Martínez ◽  
Martín Ruiz Ortiz ◽  
Ángel Cequier Fillat ◽  
Inmaculada Roldán Rabadán ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Vitamin K ◽  
Real World ◽  
Vitamin K Antagonists ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Nonvalvular Atrial Fibrillation
Sign in / Sign up

Export Citation Format

Share Document